ACell logo

ACell

Developing and commercializing advanced extracellular matrix devices for effective tissue and organ repair across various surgical procedures.

VS
Surgical Innovation Associates logo

Surgical Innovation Associates

Advancing surgical care with innovative implantable devices designed by surgeons, for surgeons.

Side-by-Side Comparison

Metric ACell Surgical Innovation Associates
Founded 1999 2016
Headquarters Not tracked yet Not tracked yet
Employees 1001-5000 1001-5000
Industry Health Care, Manufacturing Biotechnology
Funding Stage Series Unknown Series B
Total Funding $8.70M $19.33M
Funding Rounds 1 3
Business Model Not tracked yet Not tracked yet
Revenue Model Not tracked yet Not tracked yet
Services Not tracked yet Not tracked yet
Target Customers Not tracked yet Not tracked yet
Taxonomy Extracellular Matrix Devices, Tissue Repair, Organ Repair, Surgical Procedures, Regenerative Medicine, MatriStem Technology, Plastic Surgery, Wound Care, Regenerative Medicine Technology, General Surgery, Innovation Surgical Care, Implantable Devices, Plastic Surgery, Reconstructive Surgery, General Surgery, Resorbable Polymers, FDA Clearance, CE Marking, Innovation, Healthcare Institutions, Chicago, Academic Collaboration, Clinical Needs, Cost Reduction
Website acell.com sia.health
ACell logo

About ACell

ACell is a company dedicated to the development and commercialization of advanced extracellular matrix devices used for effective tissue and organ repair during various surgical procedures. Founded in 1999, the company is headquartered in Columbia, Maryland, and operates a manufacturing facility in...

Surgical Innovation Associates logo

About Surgical Innovation Associates

Surgical Innovation Associates, Inc. (SIA) is a biotechnology startup based in downtown Chicago, Illinois, founded in 2016. The company is focused on advancing surgical care through the development of innovative implantable devices designed by surgeons for surgeons. SIA's flagship product, DuraSorb®...

Frequently Asked Questions

ACell — Developing and commercializing advanced extracellular matrix devices for effective tissue and organ repair across various surgical procedures.. Surgical Innovation Associates — Advancing surgical care with innovative implantable devices designed by surgeons, for surgeons.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
ACell has raised $8.70M while Surgical Innovation Associates has raised $19.33M.
ACell and Surgical Innovation Associates operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Track both companies in real time

Signal Tracker monitors ACell, Surgical Innovation Associates, and millions of companies for 40+ signal types.

One analytics cookie (Google Analytics). Cookie Policy